Lauren Pahnke makes the case for using CPC to isolate and extract CBD in a pharmaceutical setting.
In shocking news out of Deutschland, BfArM, the federal agency responsible for the management of the first tender cultivation bid, has issued a notice that it is ditching the first tender bid and will start from scratch.
Adelson makes his case for using patient input and more data to spur product innovation.
After several years of wrangling, the British appear to be finally moving forward on legitimizing medical use of cannabis.
The landmark decision to approve a drug derived from cannabis could reflect a major policy shift in the works on a federal level.
Designing a cannabis food product with GMPs, local regulations, ingredient sourcing and scalability in mind can help companies succeed quickly.
Christian Sweeney discusses four key aspects of processing cannabis: cultivation, extraction, analytics and biochemistry.
Canadian firms Canopy and Aurora dominate the medical market so far with Dutch Bedrocan a close third.
A major acquisition confirms Aurora is setting its sights on the international cannabis market.
In the 6th and final part of the Cannabis Cultivation Virtual Conference, Dr. Hope Jones, CSO of C4 Labs, discusses cannabis tissue culture micropropagation, mitigating risk from viruses and cost analyses.
